Search by Drug Name or NDC
NDC 68788-8081-03 temazepam 30 mg/1 Details
temazepam 30 mg/1
temazepam is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is TEMAZEPAM.
MedlinePlus Drug Summary
Temazepam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Temazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
Related Packages: 68788-8081-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Temazepam
Product Information
| NDC | 68788-8081 |
|---|---|
| Product ID | 68788-8081_8225fd87-6b4e-4c84-8c32-e956fd73d096 |
| Associated GPIs | 60201030000110 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | temazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | temazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | TEMAZEPAM |
| Labeler Name | Preferred Pharmaceuticals Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA071457 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68788-8081-03 (68788808103)
| NDC Package Code | 68788-8081-3 |
|---|---|
| Billing NDC | 68788808103 |
| Package | 30 CAPSULE in 1 BOTTLE (68788-8081-3) |
| Marketing Start Date | 2021-10-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |